Voorbeelden van het gebruik van Mg single dose in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Sofosbuvir(400 mg single dose sofosbuvir)/ elbasvir(50 mg once daily)/ grazoprevir 200 mg once daily.
Intravenously administered midazolam(1 mg single dose)/ Tenofovir alafenamide 25 mg once daily.
with warfarin(30 mg single dose) increased maximum prothrombin time by 93.
The mean apparent total body clearance of levofloxacin following systemic administration of a 500 mg single dose was 175+/- 29.2 ml/min.
Famotidine(40 mg single dose taken 12 hours before rilpivirine)/ Rilpivirine1.
Ciclosporin(600 mg single dose)f/ velpatasvir(100 mg single dose)d.
Pharmacokinetics are linear in the range of 50- 800 mg single dose and up to 600 mg once daily dosing over 10 days.
Sildenafil(100 mg single dose) did not affect the steady state pharmacokinetics of the HIV protease inhibitor saquinavir,
Pravastatin(40 mg single dose)/ velpatasvir(100 mg once daily)d.
In addition, pharmacokinetics of lamotrigine was studied in 12 healthy elderly subjects following a 150 mg single dose.
Rifampicin(600 mg once daily)/ ledipasvir(90 mg single dose)d.
Rifampicin(600 mg once daily)/ sofosbuvir(400 mg single dose)d.
Ciclosporin(600 mg single dose)/ sofosbuvir(400 mg single dose)f.
Cmax by approximately 14% when a 250 mg single dose was given to healthy volunteers.
Omeprazole(20 mg once daily)/ ledipasvir(90 mg single dose)c/ sofosbuvir(400 mg single dose)c.
Tacrolimus(5 mg single dose)f/ sofosbuvir(400 mg single dose)d.
No interactions were observed between sildenafil(100 mg single dose) and acenocoumarol.
In healthy subjects co-administration of Jakavi(10 mg single dose) with a strong CYP3A4 inhibitor, ketoconazole, resulted in ruxolitinib Cmax
In healthy subjects co-administration of ruxolitinib(10 mg single dose) with erythromycin 500 mg twice daily for four days resulted in ruxolitinib Cmax
In healthy subjects given ruxolitinib(50 mg single dose) following the potent CYP3A4 inducer rifampicin(600 mg daily dose for 10 days),